Gujarat launched Online portal for Drug Manufacturing License

Ayudmla Portal – Ayurveda Drugs Manufacture Licensing System is an online system for fresh application, renewal of licence, new product permissions, etc

620

Last Updated on September 23, 2021 by The Health Master

The Food and Drug Control Administration, Gujarat, has launched an online portal for Drug Manufacturing Licence System – Ayudmla, for Ayurvedic medicines. With this, Gujarat has become the first state in India to offer these facilities for Ayurvedic industry. The portal was launched during an event of GAAMA – UDAN 2021, a statement from Gujarat Ayurved Aushadh Manufacturers Association (GAAMA) said.

It added that GAAMA organised “GAAMA UDAN 2021: focussing on Difficulties, Opportunities and Scopes of Ayurvedic Industry” in Ahmedabad recently. Dr Hemant Koshia, Commissioner, FDCA, Gujarat; Dr Kamleshbhai Bhatt, Joint Commissioner – Ayurveda, FDCA, Gujarat; Anand Mehta and Priyanka Shah, Technical Officers – Ayurveda, FDCA, Gujarat were present during the launch.

Apart from it, more than 350 Ayurvedic industrialists from across the state participated in the event.

During the launch, Dr Koshiya said, “Ayudmla Portal – Ayurveda Drugs Manufacture Licensing System is an online system for fresh application, renewal of licence, new product permissions, etc. A training session of the portal was also organised for the members of GAAMA during the event.”

Adding to it, Jaman Malaviya, President, GAAMA, said, “This was a breakthrough event not only for attendee GAAMA members, but for an entire Ayurvedic industry of Gujarat. Considering the recent surge of popularity of Ayurvedic medicine across the world, it is a need of the hour that the Ayurvedic industry gets ready to anchor its position in the international market of primary healthcare. For this, as we know, the prerequisite is to comply with international standards.”

The Ayurvedic industry is poised for a quantum jump in the next three-to-four years. The export of Ayurvedic and herbal products from India in FY2025 is expected to reach $800 million from $428 million in FY20, notified the statement.

In the coming time, the association plans to collaborate with different Ayurvedic associations across India to make a strong representation of Ayurveda, explore business opportunities for GAAMA members, provide technical assistance related to new regulations and guidelines, etc.

GAAMA has also taken an initiative to make all stakeholders sensitised about the future opportunities and to provide them all the basic knowledge sources that are required in order to achieve the international standards of their products.

Licensing procedure for manufacturing of Drugs

Latest Notifications: D&C Rules 1945

Latest Notifications: D&C Act 1940

Govt begins Anti Dumping probe: Ofloxacin & its intermediates imported…

India to get Johnson & Johnson vaccine doses next month

Covaxin kids trial over: Data to be submitted to DCGI

Lincoln Pharma plans to launch Cephalosporin products

India and Pharmacy Education: Chapter: 8

Latest Notifications regarding Pharmaceuticals

Telegram
WhatsApp
Facebook
LinkedIn
Google-news

Enter your email address:

Delivered by FeedBurner